Skip to main content

LINCOLN NATIONAL CORP

For the period ended Dec 31, 2024. Filed Feb 21, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 21, 2025

LNC$42.98+7.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

(in millions, except share data)

As of December 31,
20242023
ASSETS
Investments:
Fixed maturity available-for-sale securities, at fair value
(amortized cost: 2024 - $97,415; 2023 - $97,433; allowance for credit losses: 2024 - $46; 2023 - $19)$87,111$88,738
Trading securities2,0252,359
Equity securities294306
Mortgage loans on real estate, net of allowance for credit losses
(portion at fair value: 2024 - $232; 2023 - $288)21,08318,963
Policy loans2,4762,476
Derivative investments9,6776,474
Other investments6,5885,015
Total investments129,254124,331
Cash and invested cash5,8013,365
Deferred acquisition costs, value of business acquired and deferred sales inducements12,53712,397
Reinsurance recoverables, net of allowance for credit losses28,75029,843
Deposit assets, net of allowance for credit losses30,77629,247
Market risk benefit assets4,8603,894
Accrued investment income1,1081,082
Goodwill1,1441,144
Other assets8,1638,853
Separate account assets168,438158,257
Total assets$390,831$372,413
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities
Policyholder account balances$126,197$120,737
Future contract benefits39,80739,864
Funds withheld reinsurance liabilities16,90717,641
Market risk benefit liabilities1,0461,716
Deferred front-end loads6,7305,901
Payables for collateral on investments10,0208,105
Short-term debt300250
Long-term debt5,8565,699
Other liabilities7,2617,350
Separate account liabilities168,438158,257
Total liabilities382,562365,520
Contingencies and Commitments (See Note 17)
Stockholders’ Equity
Preferred stock – 10,000,000 shares authorized:
Series C preferred stock – 20,000 shares authorized, issued and outstanding
as of December 31, 2024, and December 31, 2023493493
Series D preferred stock – 20,000 shares authorized, issued and outstanding
as of December 31, 2024, and December 31, 2023493493
Common stock – 800,000,000 shares authorized; 170,380,646 and 169,666,137 shares
issued and outstanding as of December 31, 2024, and December 31, 2023, respectively4,6744,605
Retained earnings7,6454,778
Accumulated other comprehensive income (loss)(5,036)(3,476)
Total stockholders’ equity8,2696,893
Total liabilities and stockholders’ equity$390,831$372,413

See accompanying Notes to Consolidated Financial Statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.